HUM Humana (HUM) Q4 FY24 earnings call
Humana reaffirmed its 2025 outlook, emphasizing a commitment to achieving a 3% individual MA margin despite ongoing industry volatility and regulatory headwinds. The company is focused on operational improvements across product experience, clinical excellence, and back-office efficiency, particularly in Stars ratings recovery and Medicaid growth, while prudently managing its balance sheet. New leadership aims to bring fresh perspectives to navigate this transition period.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
HUM operating KPIs by quarter
| KPI | This call Dec 2024 Q4 FY24 | Mar 2025 Q1 FY25 | Jun 2025 Q2 FY25 | Dec 2025 Q4 FY25 | Mar 2026 Q1 FY26 | Jun 2026 Q2 FY26 | Change vs prior quarter |
|---|---|---|---|---|---|---|---|
| Employees | 65KI also just want to thank the 65,000 associates that we have who are serving our members and patients every day.Source: earnings call transcript | 65KI also want to thank our 65,000 associates who serve our members and patients every day.Source: earnings call transcript | 65KAnd finally, I want to thank our 65,000 associates who serve our members and patients every day.Source: earnings call transcript | 65KWith that, I would thank you for joining us this morning and for your interest in Humana, and I want to thank -- say thanks to our 65,000 associates who serve our members and our patients every day.Source: earnings call transcript | 65KAnd I also want to say thank you to our 65,000 associates who serve our members and our patients every day.Source: earnings call transcript | 65KAnd I also want to thank, as we always do, the 65,000 associates who make this place work, who serve our members, who serve our patients each and every day.Source: earnings call transcript | 0% |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.